News on Merck (Ticker: MRK) continually updated from thousands of sources around the net.
24 min ago | BioSpace
Merck Announces Second-Quarter 2014 Financial Results * Second-Quarter 2014 Non-GAAP EPS of $0.85, Excluding Certain Items, and GAAP EPS of $0.68 * 2014 Full-Year Non-GAAP EPS Target of $3.43 to $3.53, Excluding Potential Venezuelan Bolivar Devaluation and Certain Other Items; 2014 Full-Year GAAP EPS Target of $4.44 to $4.77 * 2014 Full-Year ... (more)
4 hrs ago | Barron's
Even though Merck doesn't plan an international marriage to cut its tax bill, its shares are rallying today on solid results in the latest quarter.
6 hrs ago | WKXW-FM Trenton
A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double second-quarter profit, improve its profit forecast and top analysts' expectations.
9 hrs ago | Newsday
United Parcel Service driver Marty Thompson starts his truck up after making a delivery in Cumming, Ga.
11 hrs ago | Ledger-Enquirer.com
The Whitehouse Station, New Jersey-based company said net income increased to $2 billion, or 68 cents per share, from $906 million, or 30 cents per share, in the same quarter a year earlier.
11 hrs ago | WTHR-TV Indianapolis
Most of the 1,200 people driven to evacuate by a Northern California wildfire that destroyed 13 homes have been told they can safely return after a series of steady gains in the firefight.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co ., Inc .
Management has not lost focus. Merck has a plan to attack and grow its share in immuno-oncologyand entering/dominating the hepatitis C and vaccines market.
While many industry watchers expect Pfizer to re-engage with Britain's AstraZeneca in coming months, some say the U.S. drugmaker should consider targets more focussed on biotechnology, a strategy that has paid off for Merck & Co Although Pfizer is conducting trials of promising products - including breast cancer drug palbociclib and vaccines ... (more)
Merck & Co., which is reorganizing to slash $2.5 billion in costs and 8,500 workers, has informed Pennsylvania officials that it will cut 600 jobs at facilities in North Wales and Lansdale.
We pitch two companies from the pharmaceutical sector, Merck and AbbVie, against one another in the latest installment of our Head-To-Head series.
MRK is the single most expensive company in the DJIA by price to earnings, nearly double the DJIA's median of 18.4. I discussed the most undervalued companies currently in the Dow Jones Industrial Average in Chevron: The Most Undervalued DJIA Component , which featured a slight focus at the end of the article on Chevron, the most undervalued ... (more)
Inovio Pharmaceuticals is the key developer of DNA-based vaccines. This relatively new method of inducing the immune system to destroy a bacteria, virus or cancer has been controversial among investors.
Merck , known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.44 per share of the company's common stock for the fourth quarter of 2014.
Updated: Tue Jul 29, 2014 04:10 pm
Copyright © 2014 Topix LLC